Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FFLN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, is structured as a firm fixed-price contract with no set-aside designation. This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for pharmaceutical supply to Department of Defense medical facilities.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorized on November 13, 2025. The parent contract encompasses a 30-month base period with three 30-month option periods and enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables. The company's demonstrated performance across multiple delivery orders and its established federal contracting history since 2001 position it as a critical pharmaceutical supplier supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FFLN8?
SPE2DR26FFLN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FFLN8 worth?
The government has obligated $16,584 on SPE2DR26FFLN8.
Is contract SPE2DR26FFLN8 an order under another contract?
Yes. SPE2DR26FFLN8 is a delivery order under SPE2DR25D9227, an indefinite delivery contract.
Was contract SPE2DR26FFLN8 competed?
The extent of competition for SPE2DR26FFLN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award